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Background
Nasal packing is frequently used after nasal surgeries to control bleeding and prevent
adhesions. Many absorbable packing materials have been developed to avoid the drawbacks
of the traditional nonabsorbable ones and to help in wound healing.

Objective

This study was done to compare between absorbable and nonabsorbable nasal packings
regarding patient satisfaction and clinical outcome.

Patients and methods

A prospective, single‑blinded, randomized controlled clinical study was carried out in Benha
University Hospital from May 2018 to November 2019. A total of 40 patients (80 nostrils)
were enrolled in this study undergoing surgery. At the end of the procedure, the operative
cavity of each patient was randomly packed with Merocel, as a nonabsorbable material on
one side, and an absorbable material, which was sinufoam or gelfoam, on the other side.
Patients’ symptoms, including pain, nasal obstruction, and nasal discharge, were evaluated
with a visual analog scale. Objective findings about bleeding, crustations, adhesions, infection,
and mucosal edema were evaluated endoscopically. Each evaluation was done at third day,
2 weeks, 4 weeks, 6 weeks, and 12 weeks after surgery.

Results

Absorbable packings had minimal pain, less nasal obstruction scores, and lower incidence of
discharge. Bleeding was significantly higher on absorbable side early postoperatively, especially
with Gelfoam. Crustation and adhesion scores were significantly higher on Merocel‑packed sides.
Gelfoam showed crustations and adhesions more than Sinufoam. Mucosal edema score was
significantly higher in Merocel group than the absorbable. However, there was no difference at 6 and
12 weeks. Gelfoam showed only significantly higher edema than Sinufoam at 6 weeks. There was a
significant difference between absorbable group and Merocel regarding infection at 1 and 2 weeks.
There was no difference between Gelfoam and Sinufoam regarding infection except at 6 weeks.

Conclusion

Absorbable packings are associated with less discomfort, more bleeding, and fewer
complications.
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Introduction
Nasal packing materials are generally used in various
endonasal surgical procedures, including septoplasty,
turbinoplasty, and paranasal sinus surgeries. Nasal
packs are intended to give hemostasis after epistaxis or
surgical procedures; support the cartilaginous and bony
nasal structure, nasal conchae or soft tissue (e.g., sliding
flaps); and prevent synechiae or stenosis, particularly
following sinus procedures [1].
Conventional nasal packings incorporate those
regularly utilized removable materials like dressing,
cotton, and sponge, regardless of whether they are
coated by glove fingers or any chemicals [2].
These packings have a few favorable circumstances
including availability, modest cost, simple control, and

adequate supporting capacity. Anyway, conventional
packings are censured for their different downsides
such as nasal airway blockage, pressure headache,
painful mouth, and pharynx dryness because of
prolonged mouth breathing. What is more, prolonged
packing time may cause infection [3].
Removal of nasal packs is regularly the most painful
part of surgical procedure for patients. The pain might
be brought about by dislodgement of the blood clot and
adherent tissues or following adherence of traditional
nasal tampons to the first bleeding site [4]. Moreover,
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nasal packing additionally requires a hospital stay
and administration of antibiotics and it meddles with
nasal physiology. Moreover, packing removal can
cause mucosal damage bringing about bleeding. These
drawbacks related with removable nasal packings have
prompted continuous advancement of biodegradable/
absorbable materials not requiring ensuing removal [5].

diseases
(diabetic,
hypertensive,
hepatic,
coagulation disorder, immunodeficient) that
may affect outcomes. Approval from the Ethical
Committee of ENT Department, Benha University
was obtained. In addition, informed consent was
obtained from all patients before enrollment.

There is no commonly perceived standard for what
sorts of materials ought to be utilized, for how long
packs ought to stay put, or when indicated, nasal
packs ought to apply pressure, function as a barrier,
fill performed spaces, or create moist environment
to facilitate physiological hemostatic and reparative
processes [1,6].

Study design

Sinufoam (ArthroCare) (Stammberger’s SinuFoam)
is a foam/gel produced using carboxy methylcellulose
(CMC) derivative. CMC can absorb many times its
weight in water. In the gel form, it has just been
hydrolyzed preceding placement in the nasal cavity.
In this way, in spite of the fact that it accomplishes
some hemostasis by absorbing water in blood, it
basically accomplishes hemostasis by pressure. It
likewise gives a moist environment for wound and
with its viscosity and thickness, gives a scaffold for
epithelialization [5].
CMC is a plant‑sourced polysaccharide biomaterial
that is an intense activator of the coagulation cascade
and is in the form of a mesh, foam, or gel [7].
Aim

This study was done to compare the efficacy of the
absorbable nasal packings (Sinufoam or Gelfoam) and
nonabsorbable Merocel on wound healing and patient
satisfaction.

Patients and methods
Patients

We enrolled 40 patients (80 nostrils) undergoing
different nasal surgeries at Benha University
Hospital, in a prospective, single‑blinded,
randomized controlled study between May 2018
and November 2019. Inclusion criteria were age
between 18 and 45 years, with deviated septum
and/or hypertrophied inferior turbinate, bilateral
chronic rhinosinusitis requiring surgery, and a
difference of two or less in the Lund‑MacKay
computed tomography scan. Exclusion criteria
were history of previous nasal surgery, unilateral
disease or massive sinonasal polyposis in patients
with rhinosinusitis, and other underlying

As the difference between Sinufoam/Gelfom and
Merocel was obvious, we proceeded as a single‑blinded
study. Patients were randomized to determine which
side was to receive absorbable packing (CMC/gelfoam)
intraoperatively. The other side received nonabsorbable
packing (merocel) at the time of procedures. Groups
were as follows:
(1) Group I: 40 nasal openings with absorbable nasal
packing
(2) Group II: 40 nasal openings with nonabsorbable
nasal packing.
Group I was randomly divided into either of the
following:
(1) Gelfoam group: 20 patients (20 nasal openings)
with Gelfoam on the absorbable side and Merocel
on the other side
(2) Sinufoam group: 20 patients (20 nasal openings)
with Sinufoam (Stammberger’s SinuFoam) on the
absorbable side and Merocel on the other side.
Preoperative evaluation of patients was done through
a full history, clinical examinations, nasal endoscopy,
radiological, and laboratory investigations.
Materials

SINUFOAM (Stammberger’s SinuFoam) is a
CMC‑based dressing, which begins as a dry CMC
fiber inside a syringe. When appropriately blended
in with sterile water, the CMC gels to form a viscous
dissolvable foam that adjusts to the nasal cavities while
giving a moist, hydrocolloid physical barrier (Fig. 1a-c).
Gelfoam (cutanplast, absorbable hemostatic gelatin sponge)
is porous, water‑insoluble hemostatic agent (Fig. 2a and b).
Merocel (polyvinyl acetate) is the widespread traditional
non-absorbable material composed of hydroxylated
polyvinyl acetate
Operative procedure

Patients underwent nasal surgeries including
septoplasty (SMR) and/or inferior turbinoplasty or
functional endoscopic sinus surgery (FESS). The
operative procedures were performed under general
anesthesia by senior staff members.
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SMR was carried out with resection of most of the
deviated cartilaginous and bony septum with or
without inferior turbinoplasty. Internal nasal splints
were inserted into both nasal cavities and fixed by 3‑0
Vicryl sutures.

analog scale (VAS) of 0–10, where ‘0’ signifies no
symptoms are present, and ‘10’ signifies the most severe
symptom. This includes pain, nasal obstruction, and
nasal discharge (Table 1 and Fig. 3).

Surgical procedures of inferior turbinate involved
lateralization followed by resection of about half of
the posterior part of the turbinate with the aid of an
endoscope.

Objective assessment

The extent of FESS varied according to the extent of
disease and surgeon’s individual practice, but usually
classic FESS steps were followed.
Postoperative

All patients received systemic antibiotics (amoxicillin
plus clavulanic acid), pain medications, steroids, and
alkaline nasal wash after pack removal. Removal of
packing was at third day after surgery, Merocel was
removed entirely. In contrast, the absorbable packing
of CMC or Gelfoam was in situ. Remnants of CMC
or Gelfoam were suctioned in follow‑up visits if were
found.
Follow‑up assessment

Patients returned for postoperative visits. We
scheduled evaluation before removal of pack, during
removal (third day), 2 weeks, 4 weeks, 6 weeks, and
12 weeks after surgery.

The patients were evaluated endoscopically after
surgery. The operative cavity was evaluated for
bleeding, the presence of synechia, crusts, appearance
of secretions, and appearance of mucosa (Table 2a-e).
Statistical analysis

Data management and statistical analysis were done
using SPSS vs. 25 (IBM, Armonk, New York, USA).
Numerical data were summarized as medians and
ranges. Comparisons between both groups were done
using Wilcoxon test for numerical data. Categorical
data were compared using 2 test or Fisher’s exact test
if appropriate. All P values were two sided. P values less
than 0.05 were considered significant.

Results
A total of 40 patients were included in this study,
comprising 25 (62.5%) males and 15 (37.5%) females,
having an age range from 15 to 45, with a mean age of
30 years (Table 3A).
The presenting clinical symptoms in patients of our
study are nasal obstruction presented in 20 (50.0%)
Table 1 Grading scale for subjective assessment

Subjective assessment

Subjective patients’ data were acquired using rated
symptoms compared between two sides. All patients
were approached to rate their symptoms on a visual
Figure 1

Criteria

Score

Pain
No
Light
Moderate
Intolerable
Nasal obstruction
No
Mild
Moderate

0
1‑4
5‑6
7‑10
0
1
2

Severe
a

b

3

Figure 2

c
(a) Gross picture of sinufoam gel preparation. (b) Sinufoam after
dissolving during infusion into nasal cavity. (c) Endoscopic view of
sinufoam in the operative cavity.

a

b

(a) Endoscopic view of gelfoam. (b) Gross picture of gelfoam.
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Table 2: Grading scores for objective assessment
Score
(a) Grading
0
1
2
3
(b) Grading
0
1
2
3
(c) Grading
0
1
2
3
0
1
2
3
(e) Grading
0
1
2
3
Age
Sex [n (%)]
Male

Criteria
score for bleeding
No bleeding
Minimal (confined to nasal cavity)
Moderate (bleeding out of nasal cavity) (cottonoids soaked with phenylephrine hydrochloride)
Severe (repacking with merocele)
score for adhesions
No
Mild (visible, easy to detach)
Moderate (hard to detach )
Severe (need synechiolysis)
score for crustations
No
Mild
Moderate
Sever
No
Mild (scanty mucopurulent discharge)
Moderate (gross mucopurulent discharge)
Severe (profuse mucopurulent discharge)
score for Mucosal edema

Female

No
Mild (no obvious cavity reduction, spacious maxillary sinus)
Moderate (obvious reduction with narrowing sinus orifice)
Middle turbinate exposed to lateral wall of nasal cavity
30±7
25 (62.5)
15 (37.5)

General characteristics of study population (n=40).

patients, nasal discharge presented in 15 (37.5%)
patients, headache presented in 15 (37.5%) patients,
hyposmia presented in 10 (25.0%) patients, facial
pain presented in 20 (50.0%) patients, and postnasal
discharge presented in 15 (37.5%) patients.
The most frequent endoscopic finding was discharge
with no polypi (40.0%), whereas the least frequent was
hypertrophied inferior turbinate (HIT) (5.0%).
The most frequent operation done was FESS (75.0%)
(Table 3B).
The absorbable packing material (group I) was randomly
assigned to 25 right nasal cavities (62.5%) and 15 left
nasal cavities (37.5%). The nonabsorbable (group II)
was assigned accordingly in 25 left and 15 right
cavities (Fig. 4).
Subjective assessment

All 40 patients answered the VAS about pain before
pack removal, during removal, and follow‑up visits.
Before removal of pack

On the absorbable side (group I).

Table 3a: General characteristics of study population (n=40)
Age
Sex

Mean±SD 30±7
Male
Female

n %     25 (62.5%)
n %     15 (37.5%)

Table 3B: Operations done of study population
Operations
FESS
Septoplasty
Septoturbinoplasty
Turbinectomy

n (%)
30 (75.0)
3 (7.5)
5 (12.5)
2 (5.0)

FESS, functional endoscopic sinus surgery.

Pain score measured 1 h postoperatively, ranged from
0 to 7 (median 4), 3 h ranged from 0 to 7 (median 7),
12 h ranged from 0 to 7 (median 3), 24 h ranged from
0 to 4 (median 2), and 48 h ranged from 0 to 4 (median
0). On Merocel side (group II), pain score measured
1 h postoperatively ranged from 5 to 9 (median 7),
3 h ranged from 5 to 9 (median 7), 12 h ranged from
4 to 7 (median 6), 24 h ranged from 0 to 7 (median
5), and 48 h ranged 0 to 7 (median 5). There was a
highly significant difference, with P value less than
0.001 (Fig. 5a).
During removal of the pack, the absorbable packed
sides had lower pain scores (ranged from 0 to 4) than
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Merocel packed ones (ranged from 6 to 10), median 0
vs 7, with P value less than 0.001.
During follow‑up visits

On the absorbable side, there were lower pain scores,
which ranged from 0 to 5 (median 1) after 1 week,
ranged from 0 to 5 (median 1) after 2 weeks, ranged
from 0 to 3 (median 0) after 4 weeks, ranged from 0
to 1 (median 0) after 6 weeks, and was 0 in all patients
after 12 weeks. However, on the Merocel side, the pain
scores ranged from 0 to 8 (median 7) after 1 week,
ranged from 0 to 7 (median 5) after 2 weeks, ranged
from 0 to 5 (median 3) after 4 weeks, ranged from 0 to
5 (median 1), and ranged from 0 to 5 (median 0) after
12 weeks. There was a highly significant difference,
with P value less than 0.001 (Table 4 and Fig. 5b).
Regarding nasal obstruction, patients’ discomfort
owing to sense of nasal obstruction was much more on
the Merocel side. The difference was statistically highly
significant (P<0.05). However, there was no significant
difference in nasal obstruction between two sides
before pack removal, at third day, and after 2 weeks,
with P value greater than 0.05.
However, there was a highly significant difference in
nasal obstruction scores between the two sides, which
ranged from 0 to 1 on the absorbable side and from
0 to 3 on the Merocel side. There was no statistically
significant difference in scores after 2 and 12 weeks
postoperatively (Fig. 6).
At 1 week, nasal discharge was significantly higher
in Merocel group (37.5%) compared with absorbable
group (0%) (P<0.001). At 2 weeks, discharge was much
more on Merocel side (50.0%) than on the absorbable
side (20.0%), with a highly significant difference
(P=0.005). There was no significant difference after 4, 6,
and 12 weeks, with P value greater than 0.05 (Table 5).
Figure 3

Objective assessment

Bleeding score was higher on the absorbable side,
which ranged from 0 to 3 (median 1), than on the
Merocel side, which ranged from 0 to 2 (median 0).
This was a significantly higher difference (P=0.002). At
third day, there was no significant difference between
both groups (P=0.399). During removal of packing,
bleeding ranged from 0 to 1 (median 0) on absorbable
side, but it ranged from 0 to 2 (median 1) on Merocel
side. This was a highly significant difference (P<0.001)
(Table 6 and Fig. 7a).
Table 4 Pain score between two groups
Group I (n=40)

Group II (n=40)

P

0 (0‑4)

7 (6‑10)

<0.001

1 (0‑5)

7 (0‑8)

<0.001

1 (0‑5)

5 (0‑7)

<0.001

0 (0‑3)

3 (0‑5)

<0.001

0 (0‑1)

1 (0‑5)

0.001

0

0 (0‑5)

<0.001

Third day
Median (IQR)
1 week
Median (IQR)
2 weeks
Median (IQR)
4 weeks
Median (IQR)
6 weeks
Median (IQR)
12 weeks
Median (IQR)

IQR, interquartile range.
Table 5: Nasal discharge distribution between both groups

1 week
Positive
2 weeks
Positive
4 weeks
Positive
6 weeks
Positive
12 weeks
Positive

Absorbable
(n=40) [n (%)]

Merocel
(n=40) [n (%)]

P

0

15 (37.5)

<0.001

8 (20.0)

20 (50.0)

0.005

10 (25.0)

14 (35.0)

0.329

5 (12.5)

9 (22.5)

0.239

2 (5.0)

6 (15.0)

0.263

Figure 4
Group I
70

Group II

62.5

62.5

60

%

50

37.5

40

37.5

30
20
10
0
Rt

Lt
Side

Visual analog scale of pain.
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Side distribution.
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Figure 5

Figure 6
absorbable

8

7

median pain score

7

7
6

6
5
4

merocel

5
4

5

4
3

3

2

2
1

a

0

0
1hour

3hours

12hours

absorbable
8

7

median pain score

7

b

Median nasal obstruction scores in both groups.

merocel

Table 6 Bleeding score between both groups
Bleeding

5

5
4

3

3
2
0

48hours

7

6

1

24hours

1

1

0
during
removal

1 week

2weeks

1
0

0

4weeks

6weeks

0 0
12weeks

(a) Median pain scores (before pack removal) in both groups. (b)
Median pain scores on both sides during and after pack removal.

Regarding comparison between 3 materials used

Early postoperatively, 5.0% of patients packed with
Gelfoam showed grade 1, 35.0% showed grade 2, and
50.0% showed grade 3. On the Sinufoam side (n=20),
15.0% showed grade 1, 10.0% showed grade 2, and
no patients showed grade 3. This was a statistically
significant difference between Gelfoam and Sinufoam.
On the Merocele side (n=40), 30.0% showed grade 1,
5.0% showed grade 2, and no patients showed grade 3.
This was a statistically significant difference between
Merocel and Gelfoam. Regarding 3 materials, there
was a highly significant difference (all P<0.001).
At 3rd day, incidence of bleeding decreased to be 20.0%
on Gelfoam sides, 5.0% on Merocel sides, and no cases
reported on Sinufoam sides.
During removal, 20.0% of Gelfoam‑packed sides
showed grade 1. No cases were reported with
Sinufoam. However, 42.5% of Merocel packed side
showed grade 1 and 40.0% showed grade 2, so Merocel
had a higher bleeding frequency compared with
Gelfoam and Sinufoam. Regarding the three materials,
there was a highly significant difference (all P<0.001)
(Fig. 7b).
Bleeding was severe (score 3) with turbinoplasty,
compared with septoplasty or FESS (score 0, 1, 2).

Absorbable (n=40) Merocel (n=40)

Early postoperative
Median (IQR)
3rd day
Median (IQR)
During removal
Median (IQR)
1 week
Median (IQR)
2 weeks
Median (IQR)

P

1 (0‑3)

0 (0‑2)

0.002

0 (0‑1)

0 (0‑1)

0.399

0 (0‑1)

1 (0‑2)

<0.001

0 (0‑0)

0 (0‑0)

1.0

0 (0‑0)

0 (0‑0)

1.0

IQR, interquartile range.

Patients needed repacking with another pack with
more discomfort and more edema.
Crustation score was significantly higher in the
Merocel group compared with the absorbable group at
1, 2, 4, 6, and 12 weeks (Table 7 and Fig. 8a).
Regarding comparison between 3 materials used

At 1 week, 35% of Gelfoam group showed mild
crustations, and 40% of Sinufoam group showed mild
crustations. The Merocel group had higher crustations
compared with Sinufoam and Gelfoam, as 52% showed
mild crustations and 22% showed severe crustations.
This was a statistically highly significant difference (all
P=0.002).
At 2 weeks, crustations were higher in Gelfoam (60%)
compared with Sinufoam (30%). The Merocel group
showed higher crustations (70%) compared with
Gelfoam and Sinufoam.
At 4 weeks, no difference between the groups was seen
(all P=0.15).
At 6 weeks, the Merocel showed higher crustations
(50%) compared with Gelfoam (35%) and Sinufoam

Comparative study between absorbable and nonabsorbable nasal packings Mohamady et al.

111

(5%). This was a statistically significant difference (all
P=0.011).

adhesions. The Merocel group has significantly higher
adhesions, as 80% developed mild to severe adhesions.

At 12 weeks, 10% showed mild crustations in Gelfoam
group. The Merocel group showed higher crustations
(32.5%) compared with Sinufoam (0%). There was
a statistically significant difference (all P=0.017)
(Fig. 8b).

Figure 7

Adhesions score was significantly higher in the Merocel
group, which ranged from 0 to 2 at 2 weeks, and ranged
from 0 to 3 at 4, 6, and 12 weeks after surgery, compared
with the absorbable group, which ranged from 0 to 1
at 2 and 12 weeks, and ranged from 0 to 2 at 4 and
6 weeks. P value was 0.027, less than 0.001, less than
0.001, and 0.012, respectively. There was no significant
difference at 1and 12 weeks (Fig. 9a).
Regarding comparison between three materials used

At 1 week, 25% developed mild adhesions in Gelfoam
group, and 20% developed mild adhesions in Merocel
group. There was a statistically significant difference
between Merocele and Sinufoam and between
Sinufoam and Gelfoam.
At 2 weeks, 25% developed mild to moderate
adhesions in Gelfoam group, and 32.5% developed
mild to moderate adhesions in the Merocel group.
There was a statistically significant difference between
Merocele and Sinufoam and between Sinufoam and
Gelfoam.

a

b
(a) Median bleeding scores in both groups. (b) Bleeding score
distribution between materials used.

Figure 8
absorbable
1.2
median crustation score

Crustations were reported with turbinoplasty and
septoturbinoplasty more than FESS. Patients with
turbinoplasty with/without septoplasty needed more
strict instructions about nasal douches. They also
associated with mostly moderate to severe degree.
However, patients of FESS showed mostly mild to
moderate degree.

a

Median (IQR)
IQR, interquartile range.

0 (0‑1)

1 (0‑2)

<0.001

1 (0‑2)

1 (0‑3)

0.026

0.6
0.4
0.2

0
1week

2weeks

0

0

0 0

4weeks

6weeks

12weeks

Figure 9
absorbable merocel
1.2
median adhesions score

P

1

b

a

1

1

1

0.8
0.6
0.4
0.2

0 0

0

0 0

1week

0

2weeks

0

4weeks

0 0

6weeks

12weeks

120
100
80
%

1 week
Median (IQR)
2 weeks
Median (IQR)
4 weeks
Median (IQR)
6 weeks
Median (IQR)
12 weeks

Merocel (n=40)

meroce
1

(a) Crustation score in both groups. (b) Crustations score distribution
between materials used.

Table 7 Crustation score between two groups
Absorbable (n=40)

1

1 1

0.8

0

At 4 weeks, 40% developed mild to moderate adhesion
in Gelfoam group, and 10% developed mild to moderate
Crustation

1

60
40

0 (0‑2)

1 (0‑3)

0.006

0 (0‑2)

1 (0‑3)

0.001

0 (0‑1)

0 (0‑2)

0.002

20
0

0

1

AS.1w

b

0

1

2

AS.2w

0

1

2

3

AS.4w

Gel foam (20)

CMC (20)

0

1

2

AS.6w

3

0

1

2

3

AS.12w

Merocel (40)

(a) Median adhesion scores in both groups. (b) Adhesions score
distribution between materials used.
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At 6 weeks, the Gelfoam group had significantly
higher adhesions compared with the Sinufoam group.
The Merocel group developed adhesions with a high
frequency (62.5%) compared with the Sinufoam. This
was a highly significant difference (all P=0.001). There
was no significant difference at 12 weeks (Fig. 9b).
Adhesions were much more with turbinoplasty, and
needed synechiolysis. However, FESS was associated
with minimal scores early postoperatively.
Mucosal edema

Median mucosal edema score was significantly higher
in the Merocel group compared with the absorbable
group at 1, 2, and 4 weeks (P<0.001). There was no
significant difference in mucosal edema score at 6 and
12 weeks (P>0.05) (Fig. 10a).
Regarding comparison between three materials used

At 1 and 2 weeks, Merocel group had significantly higher
mucosal edema compared with Gelfoam and Sinufoam.
P value was less than 0.001 at 1 week and was 0.001 at 2 weeks.
At 4 weeks, there was a statistically significant
difference comparing Merocel with Gelfoam and
Sinufoam. P value was 0.022.
At 6 weeks, the Merocel group had higher edema (40%
of cases) compared with Sinufoam (20% of cases), with
significant difference. The Sinufoam was compared
with Gelfoam, with a significant difference in‑between.
There was no statistical difference in comparing all
materials (all P<0.05).
At 12 weeks, there was no significant difference
between materials used (P=0.34) (Fig. 10b).

median mucosal oedema score

absorbable

a

1 1

1

1

merocel
1

0.8
0.6

0.2
0

1week

0

0

0 0

2week

4weeks

6weeks

12weeks

%

80
60
40
20
1

2

MES.1w

b

At 1 week, infection and discharge were significantly
higher in the Merocel group (37.5%) compared with
the absorbable group (0.0%). P value was less than
0.001.
At 2 weeks, infection and discharge were significantly
higher in Merocel group (50.0%) compared with the
absorbable group (20.0%). P value was 0.005.
There was no significant differences between both
groups at 4, 6, and 12 weeks (Fig. 11a).
Regarding comparison between three materials used

At 1 week, Merocel group showed mild infection in 32.5%
and moderate in 5.0%, compared with Sinufoam (0.0%)
and Gelfoam (0.0%), with P value less than 0.001.
At 2 weeks, Merocel, Sinufoam, and Gelfoam showed
mild infection in 40.0, 16.0, and 3.0%, respectively.
Moreover, moderate infection was seen in 10.0, 4.0,
and 1.0%, respectively. However, Gelfoam was the only
side that showed severe infection. The difference was
significantly higher in Merocel group compared with
Gelfoam group and Sinufoam group (all P value 0.001).

Infection and
discharge

0

100

0

The only significant difference was at 1 week, with
P value less than 0.001, and 2 weeks, with P value of
0.021. At 1 week, infection and discharge scores were
significantly higher in the Merocel than absorbable
group. It ranged from 0 to 2 on Merocel packed sides
and from 0 to 0 on absorbable ones (Table 8).

Table 8 Infection and discharge score between two groups

0.4

120

0

Infection and discharge (I andD)

At 6 weeks, Sinufoam group did not record any
infection. Infection and discharge were statistically
significant in Gelfoam group and Merocel group
compared with Sinufoam group (all P value 0.007).

Figure 10

1.2

Mucosal edema was more frequent with turbinoplasty
with or without septoplasty more than ESS. Then no
difference after 4 weeks.
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(a) Median mucosal edema score in both groups. (b) Mucosal edema
score distribution between materials used.

Absorbable
(n=40)

Merocel
(n=40)

P

0 (0‑0)

0 (0‑2)

<0.001

0 (0‑3)

0.5 (0‑2)

0.021

0 (0‑2)

0 (0‑2)

0.377

0 (0‑2)

0 (0‑2)

0.348

0 (0‑2)

0 (0‑2)

0.149

1 week
Median (IQR)
2 weeks
Median (IQR)
4 weeks
Median (IQR)
6 weeks
Median (IQR)
12 weeks
Median (IQR)
IQR, interquartile range.
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There was no significant difference in materials at 4 or
12 weeks (all P>0.05) (Fig. 11b).
Infection was much more with turbinoplasty, compared
with FESS, especially early postoperatively (Figs. 12-16).

Discussion
There is no worldwide estimation framework for
outcomes related with nasal packings after surgeries,
so the identification of a predominant nasal packing
material is troublesome, although certain materials
appear to be more viable than others in accomplishing
incredible postoperative results [8].
Figure 11
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Nasal packing has been used to control bleeding after
surgery and helps mucosal healing. Unfortunately,
several drawbacks appeared like infection, breathing
troubles, and discomfort [9].
Traditional nonabsorbable packing gives hemostasis
through pressure and has been well known because
of its availability and low cost. However, its removal
after surgery is very painful and considered the worst
procedure after surgery [10]. They are as yet effective
in accomplishing certain results; however, newer
absorbable substances might be similarly as successful
and keep away from the drawbacks related with nasal
packing removal [11].
Emerging absorbable packing materials have put
authors in a great debate about which type of nasal
packing, whether absorbable or not, has a better effect
on subjective and objective outcomes [12].
Different materials used in different studies do not
allow for selection of certain materials. Moreover, some
prefer not using any packs at all. Absorbable packings
have been developed in recent years.
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(a) Infection and discharge distribution in both groups. (b) Infection
and discharge score distribution between materials.

Figure 13

Nasal endoscopy: Synechia at multiple points (severe degree:
obstructing) with Gelfoam after 4 weeks. Black arrows: synechia.

Figure 14

a

Nasal endoscopy: crustations with Gelfoam after 1 week.

b

(a) Nasal endoscopy: crustations with Merocel after 2 weeks. Black
arrow: crustations (b) nasal endoscopy: crustations with Merocel
after 4 weeks.
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Figure 15

Figure 16

Nasal endoscopy: mucosal edema with Gelfoam after 2 weeks. Black
arrow: middle turbinate exposed to lateral wall of nasal cavity denoting
severe degree of edema.

Nasal endoscopy: remnants of Sinufoam after 7 days with mild oozing
and no crustations.

These absorbable materials can be one of three
categories, dependent on the chemical composition:
extracellular matrix‑based compounds (gelatin
film, gelatin foam, flowable gelatin – thrombin
admixture, and hyaluronic acid), coagulation cascade
precipitants (fibrin sealant), and natural/synthetic
biopolymers (CMC, extracellular matrix, microporous
polysaccharide hemispheres, polyethylene glycol,
chitosan gel, and polyurethane foam) [8].
There are no known standards for which type of packs to
be used, when indicated, and the optimum duration for
placement. However, packs should apply pressure, fill
spaces, and effectively help hemostatic and reparative
process [6]. The most important consideration after
nasal surgeries are patient satisfaction, minimize
bleeding and discomfort associated with packing
removal, and also proper healing of mucosa.
In our study, patients had lower pain score on the
absorbable side than on the Merocel side postoperatively,
during pack removal, and early follow‑up visits.
The estimation of pain presents a few issues, yet VAS
can be used to measure pain with high affectability and
reproducibility [13]. The absorbable material begins to
degrade in the first 24 h after application, and with
proper nasal douches using saline, it terminates in
10 days after surgery, therefore does not cause much
discomfort and bleeding. Merocel packing causes more
damage to nasal mucosa with formation of blood clots
around it, therefore causes much discomfort.
Many studies reported that discomfort occurred with
Merocel, such as Berlucchi et al. [14] who compared it
with Merogel (Hyaluronic acid); Lu and Zhang [15]
and Wang et al. [9] who compared it with Nasopore;

and also Leunig et al. [16], who detected that there was
no difference between CMC packing and no packing
at all. Nasopore was also compared with Merocel after
FESS by Shoman et al. [17] and after septoplasty
by Kim et al. [18], Yilmaz et al. [19], and Romano
et al. [20].
Subjective parameters such as nasal blockage and
discharge were also assessed and were generally lower
for the absorbable side.
Nasal obstruction showed no statistically significant
difference between both sides at third day and 2 weeks
postoperatively.This was caused by the start of resorption
of the packing which completed at 7–10 days. Nasal
obstruction was much more on the Merocel side
because of much mucosal edema and secretions. Nasal
discharge was much more on the Merocel side with a
statistically highly significant difference at first 2 weeks
after surgery and then showed no difference between
absorbable and nonabsorbable. The same observations
have been reported by Al‑Madani et al. [21], Berlucchi
et al. [14], Wang et al. [9], Kim et al. [18], and Yilmaz
et al. [19].
This study demonstrated that absorbable packing
does not significantly reduce postoperative bleeding.
Bleeding was significantly higher on the absorbable
side early postoperative, and then no significant
difference between both sides at third day. On Gelfoam
side, bleeding was significantly higher compared with
Sinufoam and Merocel (90 vs 25 and 35%, respectively).
The Merocel group showed higher bleeding incidence
compared with Sinufoam and Gelfoam during
removal (82.5 vs 0 and 20%, respectively). As there was
no need to remove the absorbable packing, no mucosal
injury occurred, so no significant bleeding was recorded.
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This is consistent with the results of Lu and Zhang [5],
who did not report any difference between Merocel
and absorbable pack (AquacelAg). Moreover, Saedi
et al. [22] showed that there was no significant
difference between Merocel and no packing. Frienkiel
et al. [23] found no difference for hemostasis between
hyaluronic acid and no packing. Another study by
Shoman et al. [17] compared Nasopore with Merocel
placed in a vinyl glove finger and found no significant
difference. Cho et al. [24] compared Merocel with
absorbable Cutanplast and reported more significant
bleeding on removal. Karkos et al. [25] evaluated
CMC Sinu‑Knit (small dry pack, mixed with saline
before use) and found oozing early postoperative, but
no interventions were needed.
On the contrary, the better effect of biodegradable
materials on hemostasis was reported. Stankiewicz [26]
stated that Flosel was better compared with Merocel. Gall
et al. [27] found Flosel (gelatin‑thrombin admixture) to
be a better hemostatic pack compared with no packing.
Beyea and Rotenberg [28] reported the same result
with Flosel, when its capabilities were compared with a
plant‑based polysaccharide (HemoStase; Cryolife Inc.,
Kennesaw, Georgia). Al‑Madani et al. [21] reported
the same hemostatic effect with different absorbable
materials used (gelfoam, surgiflo, and sinufoam).
Moreover, Kastl et al. [7] showed that oxidized cellulose
powder is more effective than PVA in controlling
bleeding. Kim et al. [18] showed that 18.8% of those
packed with absorbable synthetic polyurethane foam
following FESS had bleeding compared with 81% of
the Merocel group. Additionally, Romano et al. [20]
showed the same result with the Nasopore.
Regarding crustations, the absorbable side recorded
significantly lower scores than the Merocel. At fourth
week, no significant difference was recorded. This can
perhaps be explained by the fact that there is no need
for removal of the absorbable packs, so there is less
crusting and secretions. Later, crusts disappear. This
agrees with Romano et al. [20] and Shoman et al. [17].
In this study, there was no significant difference in first
week and 12 weeks regarding adhesion formations
between absorbable and nonabsorbable packed sides.
The difference was at 2, 4, and 6 weeks. Merocel had
higher adhesion scores than the absorbable ones. This
perhaps was due to complete resorption of materials
with no remnants and respect of regular intense nasal
rinsing during recovery period.
This agrees with Romano et al. [20] who found reduction
of adhesions in Nasopore group. Hu et al. [29] found
that there was a decrease in the rate of synechia among
patients who got absorbable packings compared with
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those who received no packing. Berlucchi et al. [14]
performed a prospective randomized controlled study
looking at the effects of Merogel and standard
nonabsorbable packing at 2, 4, and 12 weeks after ESS
in 66 patients. They found lower rates of adhesions
formation in the Merogel group at both 4 and 12 weeks
after the operation.
In contrast, Chandra et al. [30] performed a randomized
controlled trial contrasting the effects of Floseal and
thrombin‑soaked gelatin foam, and they found that
Floseal significantly increased adhesion. Baumann
and Caversaccio [31] in a prospective nonrandomized
study showed that there was a little difference in the
rate of synechia between Floseal and Merocel. Wang
et al. [9] showed that the absorbable nasal packing
was not associated with a significantly lower risk of
synechia after FESS compared with traditional nasal
packing. Miller et al. [32] in a randomized, controlled
study stated that the rate of synechia formation in
both groups at about 2 months after the operation was
nearly the equivalent. Al‑Madani et al. [21] showed
similar results.
Regarding CMC, Szczygielski et al. [5] compared it
with no packing. CMC foam performed similarly to
PVA sheathed in a latex glove finger for hemostasis
and wound healing. Kastl et al. [7] performed a
prospective study comparing CMC‑gel or Sinu‑knit
with no packs after FESS. There were no differences in
patient comfort (nasal obstruction, headache, pressure,
and sleep disturbance), wound healing (crustations,
adhesions, granulations, and wound closure), and
postoperative hemorrhage. Moreover, CMC with
dexamethasone was evaluated by Rudmik et al. [33]
and found it equal to unmedicated CMC for wound
healing.
The degree of mucosal edema reflects the degree of
operative trauma to mucosa and underlying infection.
This can cause temporary obstruction with consequent
persistence of postoperative symptoms, so steroids are
used to decrease edema.
In this study, edema score was significantly lower on
the absorbable side than the Merocel side. Incidence of
edema was significantly higher on the Merocel‑packed
sides compared with Gelfoam and Sinufoam packed
sides till the sixth week. Then no difference was
recorded. This was against the results reported by Lu and
Zhang [15], Wee et al. [34], and Al‑Madani et al. [21].
Another important issue to consider is the significant
reduction in infection and discharge at first week on
the absorbable side. This is the same observation of
Romano et al. [19] Wormald et al. [33], who reported
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that Merogel has no significant benefit in terms of
synechia, edema, and infection.
In this study, we compared absorbable with traditional
nonabsorbable packing to clarify the effect on wound
healing, represented in crustations, adhesions, mucosal
edema, and secretions. Long‑term follow‑up was
planned for better long‑term results.

Conclusion
Absorbable nasal packings can be a good alternative
to traditional packings, as patients’ comfort is higher
when using Sinufoam or Gelfoam compared with
Merocel. This comfort is associated with minimal
pain, nasal blockage, and discharge. Using these packs
helps to avoid bleeding during removal of traditional
packs. However, they are also associated with low
ability of hemostasis early postoperatively. Sinufoam
and Gelfoam seem to decrease adhesions, crustations,
mucosal edema, and infection, especially Sinufoam.
This helps for better aeration, repair, and regain of nasal
physiology. Gelfoam was associated with a very high
incidence of bleeding.
Recommendation

We recommend CMC foam to be a safe, accepted, and
well‑tolerated alternative to the traditional packings.
More studies should be conducted to evaluate
hemostatic properties. This is needed to be available
with lower cost. Gelfoam needs more studies.
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